RIM
ANIP icon

Regent Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

Regent Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,280
Closed -$589K – 205
2020
Q4 		$589K Sell
20,280
-16,699
-45% -$478K 0.16% 114
2020
Q3 		$1.04M Sell
36,979
-2,600
-7% -$77.4K 0.32% 78
2020
Q2 		$1.28M Sell
39,579
-1,000
-2% -$35.9K 0.43% 60
2020
Q1 		$1.65M Sell
40,579
-750
-2% -$39.9K 0.68% 41
2019
Q4 		$2.55M Buy
41,329
+1,670
+4% +$111K 0.78% 35
2019
Q3 		$2.89M Buy
39,659
+650
+2% +$48.6K 0.95% 29
2019
Q2 		$3.21M Sell
39,009
-4,030
-9% -$287K 1.04% 26
2019
Q1 		$3.04M Sell
43,039
-4,300
-9% -$253K 1.01% 25
2018
Q4 		$2.13M Buy
47,339
+900
+2% +$47.2K 0.8% 38
2018
Q3 		$2.63M Buy
46,439
+6,675
+17% +$408K 0.82% 34
2018
Q2 		$2.66M Buy
39,764
+3,799
+11% +$237K 0.89% 33
2018
Q1 		$2.09M Buy
35,965
+2,965
+9% +$188K 0.71% 44
2017
Q4 		$2.13M Buy
33,000
+5,550
+20% +$345K 0.7% 43
2017
Q3 		$1.44M Buy
+27,450
New +$1.31M 0.49% 64

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Regent Investment Management's ANIP Position: Q1 2021 in Review

Regent Investment Management sold out of ANI Pharmaceuticals (ANIP) in Q1 2021, closing a stake of 20,280 shares — an estimated $589K sold.

Regent Investment Management first reported a position in ANIP in Q3 2017 and held it in 14 quarters. The position peaked at $3.21M in Q2 2019. 106 funds tracked by Wall St. Rank hold ANIP as of Q1 2021.

  • Regent Investment Management reported no remaining ANI Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Regent Investment Management sold 20,280 ANI Pharmaceuticals shares in Q1 2021, an estimated $589K.
  • Regent Investment Management first reported a position in ANI Pharmaceuticals in Q3 2017 and held it in 14 quarters.
  • Regent Investment Management's ANI Pharmaceuticals position peaked at $3.21M in Q2 2019.
  • 106 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2021.

Based on Regent Investment Management's 13F filing for Q1 2021, filed 20 Apr 2021.